Botulinum Toxin for Glabellar Rhytids: from Standardized Injections to Personalized and Long-Lasting Strategies
Aesthetic Surgery Journal · 13.11.2026
DOI: 10.1093/asj/sjag243 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aesthetic Surgery Journal, online erschienen am 13.11.2026. Verfasst von Wenqi Hou und 5 weiteren Autor:innen. Die Arbeit nennt 84 Literaturangaben.
Abstract (Originalsprache)
Glabellar rhytids are among the most prevalent dynamic facial wrinkles and are primarily driven by the repetitive contraction of several facial muscles, including the corrugator supercilii, procerus, and depressor supercilii. Botulinum toxin type A (BoNT-A) has been the first-line treatment for dynamic glabellar wrinkles since 2002. However, conventional standardized injection protocols based on fixed points and doses fail to accommodate individual anatomical variability or to meet the growing patient demand for personalized, long-lasting outcomes. This narrative review, informed by a structured search of PubMed and the China National Knowledge Infrastructure through July 2026, summarizes recent advances in BoNT-A treatment for glabellar rhytids, encompassing the evolution from traditional standardized strategies based on anatomy and contraction patterns (eg, 3- and 5-point techniques) to personalized and long-lasting protocols. It evaluates novel formulation technologies (eg, ready-to-use liquid botulinum toxin) and combination modalities (eg, integration with dermal fillers or surgery) and compares the potential clinical settings, rationale, limitations, safety considerations, and levels of supporting evidence across approaches. Established techniques remain effective for many patients, whereas individualized strategies and high-dose, low-volume regimens may benefit selected cases. However, the evidence base remains uneven, and several emerging techniques rely largely on anatomical rationale, observational data, or expert opinion. No formal risk-of-bias assessment or meta-analysis was performed. Treatment selection should therefore remain individualized, anatomy-informed, and grounded in shared decision making. Future studies should integrate precision medicine, intelligent technologies, and rigorous clinical research. Level of Evidence: 3 (Therapeutic) For image description, please refer to the figure legend and surrounding text.
Zitieren
APA
Hou, W., Hu, Z., Meng, Y., Wu, H., Chen, M., & Zhao, Y. (2026). Botulinum Toxin for Glabellar Rhytids: from Standardized Injections to Personalized and Long-Lasting Strategies. Aesthetic Surgery Journal. https://doi.org/10.1093/asj/sjag243
Vancouver
Hou W, Hu Z, Meng Y, Wu H, Chen M, Zhao Y. Botulinum Toxin for Glabellar Rhytids: from Standardized Injections to Personalized and Long-Lasting Strategies. Aesthetic Surgery Journal. 2026. doi:10.1093/asj/sjag243
BibTeX
@article{Hou2026,
author = {Hou, Wenqi and Hu, Ziyun and Meng, Yongxia and Wu, Huihui and Chen, Mukai and Zhao, Yukun},
title = {Botulinum Toxin for Glabellar Rhytids: from Standardized Injections to Personalized and Long-Lasting Strategies},
journal = {Aesthetic Surgery Journal},
year = {2026},
doi = {10.1093/asj/sjag243}
}
EUVIMED